These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2055160)

  • 1. Zipeprol is a newly abused antitussive with an opioid spectrum and hallucinogenic effects.
    Janiri L; Mannelli P; Persico AM; Diodato S; Tempesta E
    Drug Alcohol Depend; 1991 Mar; 27(2):121-5. PubMed ID: 2055160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zipeprol: preclinical assessment of abuse potential.
    Acteo MD; Bowman E; Butelman E; Englis JA; Harrish L; Jacobson AE; Mattson MV; Medzihradsky F; Patrick G; Rowlett JK; Smith CB; Winger G; Woods JH; Woolverton WL
    Drug Alcohol Depend; 1996 Oct; 42(2):93-104. PubMed ID: 8889408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demographic characteristics of zipeprol-associated deaths in Korea.
    Chung HS; Choi HK; Kim EM; Park MJ; Chung KH; Yoo YC
    Arch Pharm Res; 1998 Jun; 21(3):286-90. PubMed ID: 9875445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An experimental study on dependence liability of zipeprol.
    Moretti V; Concettoni C; Giusti P; Re L
    Pharmacol Res; 1989; 21(2):223-9. PubMed ID: 2748508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postmortem distribution of zipeprol.
    Yoo Y; Chung H; Kim E; Kim M
    J Anal Toxicol; 1994; 18(4):213-6. PubMed ID: 7967542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dextromethorphan psychosis, dependence and physical withdrawal.
    Miller SC
    Addict Biol; 2005 Dec; 10(4):325-7. PubMed ID: 16318953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Problematic behavior of drug-dependent patients in the general hospital. A clinical and administrative approach to management.
    Peteet JR; Evans KR
    Gen Hosp Psychiatry; 1991 May; 13(3):150-5. PubMed ID: 1855654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zipeprol: primary dependence in an unaddicted patient.
    Mallaret MP; Lauby VL; Cornier PH; Barjhoux CE; Danel VC
    Ann Pharmacother; 1995 May; 29(5):540. PubMed ID: 7655144
    [No Abstract]   [Full Text] [Related]  

  • 9. [Addiction to zipeprol. Report of 2 cases].
    Silva H; Salvo J
    Rev Med Chil; 1993 Sep; 121(9):1029-31. PubMed ID: 8191152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should tolerance and withdrawal be required for substance dependence disorders?
    Carroll KM; Rounsaville BJ; Bryant KJ
    Drug Alcohol Depend; 1994 Aug; 36(1):15-22. PubMed ID: 7988354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Withdrawal treatment of drug dependent patients with the aim of achieving abstinence].
    Stohler R; Petitjean S; Hörler C; Bardeleben U; Ladewig D
    Psychiatr Prax; 1994 Jan; 21(1):10-2. PubMed ID: 8146238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zipeprol (Zinolta) abuse among American adolescents in Korea: a discussion of the problem, clinical presentation, and treatment.
    Ritchie EC; Andress D; Yi S; Styles JR
    Mil Med; 1996 Jan; 161(1):11-2. PubMed ID: 11082743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuropsychic side-effects of therapeutic doses of zipeprol]].
    Lauby V; Imbert B; Eysseric H; Dufrêne I; Mallaret M
    Rev Med Interne; 1995; 16(3):212-3. PubMed ID: 7740233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of parenteral zolpidem dependence with opioid-like withdrawal symptoms.
    Kao CL; Huang SC; Yang YJ; Tsai SJ
    J Clin Psychiatry; 2004 Sep; 65(9):1287. PubMed ID: 15367062
    [No Abstract]   [Full Text] [Related]  

  • 15. Past anabolic-androgenic steroid use among men admitted for substance abuse treatment: an underrecognized problem?
    Kanayama G; Cohane GH; Weiss RD; Pope HG
    J Clin Psychiatry; 2003 Feb; 64(2):156-60. PubMed ID: 12633124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Symptoms of hallucinogen and opiate use and withdrawal syndrome].
    Ladewig D
    Wien Med Wochenschr; 1981 Mar; 131(5):115-8. PubMed ID: 7233905
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety and efficacy of buprenorphine/naloxone in opioid-dependent patients: an Italian observational study.
    Magnelli F; Biondi L; Calabria R; Fiore A; Peluso E; Vonella D; Rota AG
    Clin Drug Investig; 2010; 30 Suppl 1():21-6. PubMed ID: 20450242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic dilemmas in substance disorders.
    Brough R
    Aust Fam Physician; 2010 Aug; 39(8):536-7. PubMed ID: 20877743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The problem of the addictive capacity of zipeprol. Results of an experimental and clinical investigation].
    Moroni F; Mannaioni PF
    Recenti Prog Med; 1986; 77(7-8):333-8. PubMed ID: 3024271
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical implications for four drugs of the DSM-IV distinction between substance dependence with and without a physiological component.
    Schuckit MA; Daeppen JB; Danko GP; Tripp ML; Smith TL; Li TK; Hesselbrock VM; Bucholz KK
    Am J Psychiatry; 1999 Jan; 156(1):41-9. PubMed ID: 9892296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.